Good update on pooled testing; dreadful headline. https://www.nytimes.com/2020/08/18/health/coronavirus-pool-te.html
The story addresses how pooled testing doesn't work when the positive rates are on the order of 10%. That's totally fair—at that point benefits are marginal.
But what isn't stressed is that the positive rate is function of two things:
1) prevalence
2) testing strategy
But what isn't stressed is that the positive rate is function of two things:
1) prevalence
2) testing strategy
Much of the potential value of pooled testing is that it makes it possible to use testing to screen asymptomatic people without known exposures. These 10+ percent positive rates come from testing suspected cases.
So if we started to use pooled testing to screen asymptomatic people, we would be getting the kinds of positive rates that make pooled testing worthwhile.
In that situation, we are also less concerned about the occasional false negative due to dilution.
In that situation, we are also less concerned about the occasional false negative due to dilution.